T1	PROC 49 95	estudio para evaluar la seguridad y tolerancia
T2	CHEM 133 145	vortioxetina
#1	AnnotatorNotes T2	C3661282; vortioxetine; Organic Chemical · Pharmacologic Substance
T3	DISO 156 165	depresión
#2	AnnotatorNotes T3	C0011570; Mental Depression; Mental or Behavioral Dysfunction | C0011581; Depressive disorder; Mental or Behavioral Dysfunction
T4	PROC 214 316	Estudio de extensión a largo plazo sin interrumpir el tratamiento, abierto y con flexibilidad de dosis
T5	CHEM 320 332	vortioxetina
#3	AnnotatorNotes T5	C3661282; vortioxetine; Organic Chemical · Pharmacologic Substance
T6	DISO 384 409	trastorno depresivo mayor
#4	AnnotatorNotes T6	C1269683; Major Depressive Disorder; Mental or Behavioral Dysfunction
T7	DISO 411 414	TDM
#5	AnnotatorNotes T7	C1269683; Major Depressive Disorder; Mental or Behavioral Dysfunction
T8	DISO 439 448	Depresión
#6	AnnotatorNotes T8	C0011570; Mental Depression; Mental or Behavioral Dysfunction | C0011581; Depressive disorder; Mental or Behavioral Dysfunction
T9	DISO 475 500	Trastorno Depresivo Mayor
#7	AnnotatorNotes T9	C1269683; Major Depressive Disorder; Mental or Behavioral Dysfunction
T10	PROC 703 723	estudio de extensión
T11	PROC 778 798	estudio de extensión
T12	PROC 819 830	diagnóstico
#8	AnnotatorNotes T12	C0011900; Diagnosis; Diagnostic Procedure
T13	DISO 843 868	trastorno depresivo mayor
#9	AnnotatorNotes T13	C1269683; Major Depressive Disorder; Mental or Behavioral Dysfunction
T14	DISO 870 873	TDM
#10	AnnotatorNotes T14	C1269683; Major Depressive Disorder; Mental or Behavioral Dysfunction
T15	PROC 895 902	ingreso
#11	AnnotatorNotes T15	C0021629; Institutionalization; Health Care Activity | C0184666; Hospital admission; Health Care Activity
T16	PROC 931 944	diagnosticado
#12	AnnotatorNotes T16	C0011900; Diagnosis; Diagnostic Procedure
T17	PROC 1012 1037	tratamiento a largo plazo
#13	AnnotatorNotes T17	C0023977; long-term treatment; Health Care Activity
T18	CHEM 1042 1054	vortioxetina
#14	AnnotatorNotes T18	C3661282; vortioxetine; Organic Chemical · Pharmacologic Substance
T19	PROC 1145 1158	diagnosticado
#15	AnnotatorNotes T19	C0011900; Diagnosis; Diagnostic Procedure
T20	DISO 1168 1189	desorden psiquiátrico
T21	DISO 1203 1208	manía
#16	AnnotatorNotes T21	C0338831; Manic; Mental or Behavioral Dysfunction
T22	DISO 1210 1227	trastorno bipolar
#17	AnnotatorNotes T22	C0005586; Bipolar Disorder; Mental or Behavioral Dysfunction
T23	DISO 1229 1242	esquizofrenia
#18	AnnotatorNotes T23	C0036341; Schizophrenia; Mental or Behavioral Dysfunction
T24	DISO 1250 1268	desorden psicótico
T25	DISO 1314 1361	trastorno de déficit de atención/hiperactividad
T26	DISO 1363 1367	TDAH
#19	AnnotatorNotes T26	C1263846; Attention deficit hyperactivity disorder; Mental or Behavioral Dysfunction
T27	PROC 1387 1412	tratamiento farmacológico
#20	AnnotatorNotes T27	C0013216; Pharmacotherapy; Therapeutic or Preventive Procedure
T28	CHEM 1417 1439	medicación estimulante
T29	Date 13 17	2015
T30	Date 96 109	a largo plazo
T31	LIVB 170 175	niños
#21	AnnotatorNotes T31	C0008059; Child; Age Group
T32	Date 235 248	a largo plazo
T34	LIVB 336 341	niños
#22	AnnotatorNotes T34	C0008059; Child; Age Group
T35	Age 357 371	de 7 a 17 años
T36	LIVB 529 538	Pacientes
#23	AnnotatorNotes T36	C0030705; Patients; Patient or Disabled Group
T37	LIVB 540 545	niños
#24	AnnotatorNotes T37	C0008059; Child; Age Group + C0870221; Boys; Age Group
T38	LIVB 548 553	niñas
#25	AnnotatorNotes T38	C0008059; Child; Age Group + C0870604; Female child; Age Group
T39	Age 558 579	entre >= 7 y <12 años
T41	LIVB 669 678	Pacientes
#26	AnnotatorNotes T41	C0030705; Patients; Patient or Disabled Group
T42	LIVB 802 811	Pacientes
#27	AnnotatorNotes T42	C0030705; Patients; Patient or Disabled Group
T43	LIVB 964 973	Pacientes
#28	AnnotatorNotes T43	C0030705; Patients; Patient or Disabled Group
T44	Date 1024 1037	a largo plazo
T45	LIVB 1085 1097	investigador
#29	AnnotatorNotes T45	C0035173; Research Personnel; Professional or Occupational Group
T46	LIVB 1128 1136	paciente
#30	AnnotatorNotes T46	C0030705; Patients; Patient or Disabled Group
T47	LIVB 1299 1307	paciente
#31	AnnotatorNotes T47	C0030705; Patients; Patient or Disabled Group
T48	LIVB 178 190	adolescentes
#32	AnnotatorNotes T48	C0205653; Adolescent (age group); Age Group
T49	LIVB 344 356	adolescentes
#33	AnnotatorNotes T49	C0205653; Adolescent (age group); Age Group
T50	LIVB 582 594	adolescentes
#34	AnnotatorNotes T50	C0205653; Adolescent (age group); Age Group
T33	Age 598 620	entre >=12 y <=17 años
T40	Neg_cue 1382 1386;1413 1416	otro que
#35	AnnotatorNotes T40	[Direct translation of: "other than"]
T51	PHYS 1338 1346	atención
#36	AnnotatorNotes T51	C0004268; Attention; Mental Process
T52	PROC 635 641	visita
#37	AnnotatorNotes T52	C1512346; Patient Visit; Health Care Activity
T53	Quantifier_or_Qualifier 642 647	basal
#38	AnnotatorNotes T53	C1442488; Baseline; Quantitative Concept
A1	Population_data T50 Age
A2	Population_data T31 Age
A3	Population_data T48 Age
A4	Population_data T34 Age
A5	Population_data T49 Age
A6	Population_data T37 Age
A7	Population_data T38 Age
A8	Assertion T28 Negated
A9	Status T10 History_of
#39	AnnotatorNotes T1	C0511730; Identify product efficacy and safety issues; Health Care Activity
#40	AnnotatorNotes T20	C0004936; Mental disorders; Mental or Behavioral Dysfunction
#41	AnnotatorNotes T24	C0033975; Psychotic Disorders; Mental or Behavioral Dysfunction 
#42	AnnotatorNotes T25	C1263846; Attention deficit hyperactivity disorder; Mental or Behavioral Dysfunction
#43	AnnotatorNotes T30	C0443252; Long-term; Temporal Concept
#44	AnnotatorNotes T32	C0443252; Long-term; Temporal Concept
#45	AnnotatorNotes T44	C0443252; Long-term; Temporal Concept
R1	Overlap Arg1:T1 Arg2:T30	
R2	Experiences Arg1:T31 Arg2:T2	
R3	Experiences Arg1:T48 Arg2:T2	
R4	Experiences Arg1:T31 Arg2:T3	
R5	Experiences Arg1:T48 Arg2:T3	
R6	Overlap Arg1:T4 Arg2:T32	
R7	Experiences Arg1:T34 Arg2:T5	
R8	Experiences Arg1:T49 Arg2:T5	
R9	Has_Age Arg1:T49 Arg2:T35	
R10	Has_Age Arg1:T34 Arg2:T35	
R11	Experiences Arg1:T49 Arg2:T6	
R12	Experiences Arg1:T49 Arg2:T7	
R13	Experiences Arg1:T34 Arg2:T6	
R14	Experiences Arg1:T34 Arg2:T7	
R15	Has_Age Arg1:T36 Arg2:T39	
R16	Has_Age Arg1:T36 Arg2:T33	
R17	Has_Age Arg1:T50 Arg2:T33	
R18	Overlap Arg1:T52 Arg2:T33	
R19	Has_Quantifier_or_Qualifier Arg1:T52 Arg2:T53	
R20	Overlap Arg1:T52 Arg2:T39	
R21	Has_Age Arg1:T37 Arg2:T39	
R22	Has_Age Arg1:T38 Arg2:T39	
T54	Observation 683 723	hayan finalizado el estudio de extensión
A10	Status T54 History_of
#46	AnnotatorNotes T54	C2732579; Completion of clinical trial; Finding
T55	CONC 731 745	inmediatamente
#47	AnnotatorNotes T55	C0205253; Immediate; Temporal Concept
R24	Before Arg1:T10 Arg2:T11	
R25	Before Arg1:T55 Arg2:T11	
R26	Overlap Arg1:T54 Arg2:T55	
R23	Experiences Arg1:T42 Arg2:T13	
R27	Experiences Arg1:T42 Arg2:T14	
R28	Overlap Arg1:T14 Arg2:T15	
R29	Overlap Arg1:T13 Arg2:T15	
T56	Quantifier_or_Qualifier 831 839	primario
#48	AnnotatorNotes T56	C0205225; Primary; Qualitative Concept
R30	Has_Quantifier_or_Qualifier Arg1:T12 Arg2:T56	
T57	CONC 954 959	DSM-5
#49	AnnotatorNotes T57	C4236906; Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5); Intellectual Product
R31	Used_for Arg1:T57 Arg2:T16	
R32	Used_for Arg1:T57 Arg2:T12	
R33	Overlap Arg1:T12 Arg2:T15	
R34	Overlap Arg1:T16 Arg2:T15	
R35	Experiences Arg1:T43 Arg2:T17	
R36	Overlap Arg1:T18 Arg2:T44	
R37	Used_for Arg1:T18 Arg2:T17	
R38	Experiences Arg1:T46 Arg2:T20	
T58	Quantifier_or_Qualifier 1163 1167	otro
#50	AnnotatorNotes T58	C0205394; Other; Qualitative Concept
R39	Has_Quantifier_or_Qualifier Arg1:T20 Arg2:T58	
T59	PROC 1281 1288	estudio
#51	AnnotatorNotes T59	C0008976; Clinical Trials; Research Activity
R40	Overlap Arg1:T19 Arg2:T59	
R41	Overlap Arg1:T24 Arg2:T59	
R42	Overlap Arg1:T23 Arg2:T59	
R43	Overlap Arg1:T22 Arg2:T59	
R44	Overlap Arg1:T21 Arg2:T59	
R45	Overlap Arg1:T20 Arg2:T59	
R46	Experiences Arg1:T46 Arg2:T21	
R47	Experiences Arg1:T46 Arg2:T22	
R48	Experiences Arg1:T46 Arg2:T23	
R49	Experiences Arg1:T46 Arg2:T24	
R50	Experiences Arg1:T47 Arg2:T25	
R53	Experiences Arg1:T47 Arg2:T26	
R54	Negation Arg1:T40 Arg2:T28	
R55	Used_for Arg1:T28 Arg2:T27	
R56	Experiences Arg1:T47 Arg2:T27	
R57	Experiences Arg1:T36 Arg2:T52	
R58	Experiences Arg1:T37 Arg2:T52	
R59	Experiences Arg1:T38 Arg2:T52	
R60	Experiences Arg1:T50 Arg2:T52	
#52	AnnotatorNotes T28	C0304402; Stimulant; Pharmacologic Substance (?)
R51	Experiences Arg1:T47 Arg2:T51	
A11	Experiencer T31 Patient
A12	Experiencer T48 Patient
A13	Experiencer T34 Patient
A14	Experiencer T49 Patient
A15	Experiencer T36 Patient
A16	Experiencer T37 Patient
A17	Experiencer T38 Patient
A18	Experiencer T50 Patient
A19	Experiencer T41 Patient
A20	Experiencer T42 Patient
A21	Experiencer T43 Patient
A22	Experiencer T45 Other
A23	Experiencer T46 Patient
A24	Experiencer T47 Patient
